Ducon Rights Issue 2026: Record Date, 10:13 Ratio

What Ducon has announced

Ducon Infratechnologies Limited has moved ahead with its proposed rights issue after receiving in-principle approvals from both BSE Limited and the National Stock Exchange of India Limited (NSE). The company communicated this development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The exchange approval letters are dated August 6, 2026, and the company’s disclosure referencing the approvals was made on August 7, 2026.

The rights issue, as detailed in the information available, is structured as an issuance of fully paid-up equity shares to existing shareholders. The face value is Re 1 per equity share, and the issue price is also set at Re 1 per share. While the issue is described as being proposed up to ₹25 crore, the specific rights issue size cited is ₹24.99 crore.

Rights issue size and pricing details

The rights issue comprises 24,99,42,758 equity shares, aggregating to ₹24.99 crore, offered at an issue price of Re 1 per share with a face value of Re 1 per share. The terms of payment indicate that Re 1 per share is payable in full at the time of application, meaning there is no split payment schedule mentioned in the available details.

This structure makes the offer mechanically straightforward for eligible shareholders, since the full amount is due when applying for the rights entitlement. The company has also stated that the open and close dates for the rights issue were not available at the time of the referenced update.

Record date and eligibility: key cut-offs

Ducon Infratechnologies has confirmed August 25, 2026 as the record date to determine shareholder eligibility for the rights issue. The last date to buy shares to be eligible is listed as Monday, August 24, 2026, followed by the record date on Tuesday, August 25, 2026.

The entitlement ratio is set at 10 rights equity shares for every 13 fully paid-up equity shares held on the record date. In practical terms, shareholders holding 13 fully paid-up equity shares as of the record date are eligible to receive 10 rights shares at Re 1 each, subject to the final process and timelines issued by the company.

Entitlement ratio and expected change in equity shares

The rights issue is offered in an entitlement ratio of 10:13 (10 new shares for every 13 existing shares held). The information provided also states that the issuance will increase the outstanding equity count from 32.5 million shares to 57.5 million shares.

This stated increase provides investors a clearer picture of how the share base could expand post-issue, assuming the rights issue proceeds as described. Such expansion is a key data point for shareholders evaluating dilution and the post-issue capital structure.

Exchange approvals and the regulatory milestone

The company has received in-principle approvals from both BSE and NSE for listing of the equity shares to be issued on a rights basis. These approvals, dated August 6, 2026, are a key prerequisite before the company proceeds with final steps like confirming the subscription period.

The disclosure notes that the company has been progressing through required processes and communications. The rights issue is referenced as being in line with the regulatory framework, including disclosures under Regulation 30 of SEBI LODR.

Board approvals and meeting timeline

Multiple board-related milestones are referenced in the available information. The Board of Directors is stated to have approved the rights issue in a meeting held on August 19, 2026, at the company’s registered office in Thane. Separately, the rights issue approval is also referenced as having taken place around June 12, 2026 and June 13, 2026, including authorization under Section 62(1)(a) of the Companies Act, 2013.

A board meeting was scheduled for Wednesday, August 19, 2026 at 05:30 P.M. at the registered office address in Thane, with agenda items including the issue price, entitlement ratio, terms of payment, and record date. The company also noted that the trading window would remain closed until 48 hours after the conclusion of the board meeting, in line with insider trading regulations and internal code.

Use of proceeds: what the company has stated

The rights issue is described as aimed at strengthening the balance sheet and supporting capital requirements. The use of proceeds cited includes repayment of ₹9.52 crore of unsecured loans from promoter Arun Govil and allocation of ₹7.36 crore for working capital.

These figures are presented as part of the company’s stated intent for the fundraising. Beyond these specific allocations, the broader purpose is also framed as supporting working capital needs and adjusting promoter loans.

Registrar and investor support touchpoints

Bigshare Services Pvt. Ltd. has been named as the Registrar to the Issue. Contact details for both the company and the registrar are provided in the available information, indicating where shareholders can direct rights-issue related queries once the subscription process and timelines are announced.

The company’s registered office address is listed as Ducon House, Plot No. A/4, Road No. 1, MIDC, Wagle Industrial Estate, Thane, 400604.

Key facts at a glance

Why this matters for shareholders and the market

For existing shareholders, the record date and entitlement ratio determine eligibility and the number of shares they can subscribe to at the issue price. With the issue priced at Re 1 per share and payable fully on application, the immediate cash outflow required for participation is clearly defined.

From a market perspective, the company’s stated plan to use proceeds for promoter loan repayment and working capital connects the fundraising to balance-sheet and operational objectives. Investors typically track such disclosures closely because they provide context on why capital is being raised and how it may affect leverage and liquidity.

Timeline of disclosed milestones

Conclusion

Ducon Infratechnologies’ ₹24.99 crore rights issue has crossed a key checkpoint with in-principle approvals from BSE and NSE, and the company has fixed August 25, 2026 as the record date with an entitlement ratio of 10:13. The issue is priced at Re 1 per share, payable fully on application, and Bigshare Services is the registrar. The next key update awaited is the announcement of the rights issue opening and closing dates, which were not available in the provided information.